Skip to content

Categorypharma

Researchers link surgical anesthesia in young children to adverse effects on IQ, brain structure.

Children who received general anesthesia for surgery before age 4 had diminished language comprehension, lower IQ and decreased gray matter density in posterior regions of their brain, according to a … Continue Reading Researchers link surgical anesthesia in young children to adverse effects on IQ, brain structure.

First report of world’s first implantable chip capable of measuring metabolites and drugs in real-time.

The future of medicine lies in ever greater precision, not only when it comes to diagnosis but also drug dosage. The blood work that medical staff rely on is generally … Continue Reading First report of world’s first implantable chip capable of measuring metabolites and drugs in real-time.

Researchers identify gene mutation that raises risk of nerve damage in leukemia patients using Vincristine.

Researchers from St. Jude Children’s Research Hospital have identified the first genetic variation that is associated with increased risk and severity of peripheral neuropathy following treatment with a widely used … Continue Reading Researchers identify gene mutation that raises risk of nerve damage in leukemia patients using Vincristine.

The FDA clears the first-ever newborn test to detect Severe Combined Immunodeficiency.

The U.S. Food and Drug Administration (FDA) has cleared the EnLite Neonatal TREC Kit for the company PerkinElmer, the first screening test permitted to be marketed by FDA for Severe … Continue Reading The FDA clears the first-ever newborn test to detect Severe Combined Immunodeficiency.

Higher risk of GI, major bleeding in Atrial Fibrillation patients taking Pradaxa (Dabigatran).

Patients with atrial fibrillation who take the blood thinner Pradaxa (dabigatran) are at greater risk for major bleeding and gastrointestinal bleeding than those who take warfarin, according to a new … Continue Reading Higher risk of GI, major bleeding in Atrial Fibrillation patients taking Pradaxa (Dabigatran).

Brain tumour invasion along blood vessels may lead to new cancer treatments.

NIH-funded researchers map brain tumour cells disrupting the blood-brain barrier, offering potential avenues for therapy. Invading glioblastoma cells may hijack cerebral blood vessels during early stages of disease progression and damage the brain’s protective barrier, a study in mice indicates. This finding could ultimately lead to new ways to bring about the death of the tumour, as therapies may be able to reach these deadly cells at an earlier time point than was previously thought possible.

Thoughts health innovators?

Translate »